TY - JOUR
T1 - 2016 update of the EULAR recommendations for the management of early arthritis
AU - Combe, Bernard
AU - Landewe, Robert
AU - Daien, Claire I
AU - Hua, Charlotte
AU - Aletaha, Daniel
AU - Álvaro-Gracia, Jose María
AU - Bakkers, Margôt
AU - Brodin, Nina
AU - Burmester, Gerd R
AU - Codreanu, Catalin
AU - Conway, Richard
AU - Dougados, Maxime
AU - Emery, Paul
AU - Ferraccioli, Gianfranco
AU - Fonseca, Joao
AU - Raza, Karim
AU - Silva-Fernández, Lucía
AU - Smolen, Josef S
AU - Skingle, Diana
AU - Szekanecz, Zoltan
AU - Kvien, Tore K
AU - Van Der Helm-Van Mil, Annette
AU - Van Vollenhoven, Ronald
PY - 2016
Y1 - 2016
N2 - Objectives Since the 2007 recommendations for the management of early arthritis have been presented, considerable research has been published in the field of early arthritis, mandating an update of the 2007 European League Against Rheumatism (EULAR) recommendations for management of early arthritis. Methods In accordance with the 2014 EULAR Standardised Operating Procedures, the expert committee pursued an approach that was based on evidence in the literature and on expert opinion. The committee involved 20 rheumatologists, 2 patients and 1 healthcare professional representing 12 European countries. The group defined the focus of the expert committee and target population, formulated a definition of 'management' and selected the research questions. A systematic literature research (SLR) was performed by two fellows with the help of a skilled librarian. A set of draft recommendations was proposed on the basis of the research questions and the results of the SLR. For each recommendation, the categories of evidence were identified, the strength of recommendations was derived and the level of agreement was determined through a voting process. Results The updated recommendations comprise 3 overarching principles and 12 recommendations for managing early arthritis. The selected statements involve the recognition of arthritis, referral, diagnosis, prognostication, treatment (information, education, pharmacological and non-pharmacological interventions), monitoring and strategy. Eighteen items were identified as relevant for future research. Conclusions These recommendations provide rheumatologists, general practitioners, healthcare professionals, patients and other stakeholders with an updated EULAR consensus on the entire management of early arthritis.
AB - Objectives Since the 2007 recommendations for the management of early arthritis have been presented, considerable research has been published in the field of early arthritis, mandating an update of the 2007 European League Against Rheumatism (EULAR) recommendations for management of early arthritis. Methods In accordance with the 2014 EULAR Standardised Operating Procedures, the expert committee pursued an approach that was based on evidence in the literature and on expert opinion. The committee involved 20 rheumatologists, 2 patients and 1 healthcare professional representing 12 European countries. The group defined the focus of the expert committee and target population, formulated a definition of 'management' and selected the research questions. A systematic literature research (SLR) was performed by two fellows with the help of a skilled librarian. A set of draft recommendations was proposed on the basis of the research questions and the results of the SLR. For each recommendation, the categories of evidence were identified, the strength of recommendations was derived and the level of agreement was determined through a voting process. Results The updated recommendations comprise 3 overarching principles and 12 recommendations for managing early arthritis. The selected statements involve the recognition of arthritis, referral, diagnosis, prognostication, treatment (information, education, pharmacological and non-pharmacological interventions), monitoring and strategy. Eighteen items were identified as relevant for future research. Conclusions These recommendations provide rheumatologists, general practitioners, healthcare professionals, patients and other stakeholders with an updated EULAR consensus on the entire management of early arthritis.
KW - Biochemistry, Genetics and Molecular Biology (all)
KW - DMARDs (synthetic)
KW - Early Rheumatoid Arthritis
KW - Immunology
KW - Immunology and Allergy
KW - Patient perspective
KW - Rheumatoid Arthritis
KW - Rheumatology
KW - Treatment
KW - Biochemistry, Genetics and Molecular Biology (all)
KW - DMARDs (synthetic)
KW - Early Rheumatoid Arthritis
KW - Immunology
KW - Immunology and Allergy
KW - Patient perspective
KW - Rheumatoid Arthritis
KW - Rheumatology
KW - Treatment
UR - http://hdl.handle.net/10807/94029
UR - http://ard.bmj.com/
U2 - 10.1136/annrheumdis-2016-210602
DO - 10.1136/annrheumdis-2016-210602
M3 - Article
SN - 0003-4967
SP - N/A-N/A
JO - Annals of the Rheumatic Diseases
JF - Annals of the Rheumatic Diseases
ER -